Bildkälla: Stockfoto

Alligator Bioscience Q3 2024: Approaching the Decisive Moment - Redeye

Redeye comments on Alligator's Q3 report. The main event since our last update was the ALG.APV-527 phase I readout. Considering the limited runway and intention to begin a phase III study by mid-2025, Alligator will have to sign a deal in the very near future.

Redeye comments on Alligator's Q3 report. The main event since our last update was the ALG.APV-527 phase I readout. Considering the limited runway and intention to begin a phase III study by mid-2025, Alligator will have to sign a deal in the very near future.
Börsvärldens nyhetsbrev
ANNONSER